Vine Tea Combined with a Lidocaine Microneedle Patch for Enhanced Treatment of Psoriasis

Vine tea, a traditional Chinese herbal tea with well-known medicinal properties, contains various bioactive compounds, with dihydromyricetin (DMY) standing out as particularly notable. However, the therapeutic potential of DMY is hindered by its low solubility and limited ability to penetrate cell membranes. In this study, we present a novel approach utilizing a microneedle (MN) patch loaded with DMY in combination with lidocaine (LD), referred to as the DMY-LD MN patch, to effectively target thickened skin lesions in the treatment of psoriasis. The DMY-LD MN patch demonstrated the ability to penetrate the thickened epidermal layers associated with psoriasis, enabling sustained release of DMY and LD at the site of the skin lesion. In a murine model of psoriasis, both DMY and LD showed therapeutic efficacy when administered individually. Notably, the combined DMY and LD treatment regimen exhibited superior therapeutic outcomes. The DMY-LD MN patch offers a promising treatment strategy for psoriasis due to its durability, efficacy, cost-effectiveness, and safety.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2025-10-23
DOI
https://doi.org/10.1021/acsomega.5c03831
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vine Tea Combined with a Lidocaine Microneedle Patch for Enhanced Treatment of Psoriasis

Peipei Wang, Huayi Wu, Wei Zheng, Wu Zhu et al.
ACS Omega
Psoriasis: Treatment and Pathogenesis
article

Vine Tea Combined with a Lidocaine Microneedle Patch for Enhanced Treatment of Psoriasis

Peipei Wang, Huayi Wu, Wei Zheng, Wu Zhu, Shuang Zhao, Wangqing Chen, Ziyan Chen, Ying Wang, Lijun Liu, Xiang Chen, Kai Ye, Mengting Tan, Xiaowei Liang, Xingyu Huang
article en

Abstract

Vine tea, a traditional Chinese herbal tea with well-known medicinal properties, contains various bioactive compounds, with dihydromyricetin (DMY) standing out as particularly notable. However, the therapeutic potential of DMY is hindered by its low solubility and limited ability to penetrate cell membranes. In this study, we present a novel approach utilizing a microneedle (MN) patch loaded with DMY in combination with lidocaine (LD), referred to as the DMY-LD MN patch, to effectively target thickened skin lesions in the treatment of psoriasis. The DMY-LD MN patch demonstrated the ability to penetrate the thickened epidermal layers associated with psoriasis, enabling sustained release of DMY and LD at the site of the skin lesion. In a murine model of psoriasis, both DMY and LD showed therapeutic efficacy when administered individually. Notably, the combined DMY and LD treatment regimen exhibited superior therapeutic outcomes. The DMY-LD MN patch offers a promising treatment strategy for psoriasis due to its durability, efficacy, cost-effectiveness, and safety.

ACS OmegaVol. 10(43)
Central South University (CN), SKiN Health (CA), Eye Center (SA), Beike Biotechnology (China) (CN), He Eye Hospital (CN), Xiangya Hospital Central South University (CN)
Openalex Percentile: Top 68%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.